ERIC SHEA BROADUS

Over the past few years, we have amassed an incredible collection of cancer/oncology stocks data related to diagnostics and therapeutics technologies from a spectrum of global stocks of varied business operations and market capitalizations that you could own. Additionally, we hold in our world-class database an assortment of healthcare real estate investment trusts (REITs) and health insurance stocks that provide wonderful complementary building blocks to produce cancer-focused portfolios that are richly diversified and achieve the proper risk vs return trade-offs that allow portfolios to grow. 

What separates our platform from others is the flexibility you will enjoy in building biotech portfolios that focus on the types of cancer that are of greatest interest to you personally based on what is suitable given your risk tolerance profile generated via dynamic questionnaire programming.

Simply put, what you care about is what we care about.  

Our business name sounds unmistakably like “cancer-free”. That is without coincidence and completely intentional. Please see the promo video found on the Mission & Vision page under the ABOUT header. It provides heartfelt insight into why the business name and trademarked logo have such significance in reflecting our mission and vision as a company. Being a cancer survivor myself of acute myeloid leukemia (receiving a life-saving bone marrow transplant from my younger sister more than 30 years ago), this work is personal as well as business. 

I invite you to thoroughly review the web pages, watch the promo and demo videos, read the policies / terms & conditions, and carefully peruse the examples of Form ADV Part 2A ("Brochure") and Investment Advisory Agreement ("Contract"). Click on the PRICING link at the top to review and select one of our subscription packages that fits your budget and investment requirements. You will find legal documents at the bottom of the page.

We want you as a Client and ask for your business. Your decision to subscribe to an investment package will unlock the most exciting parts of the website and provide you with value-added services that you will hopefully find enlightening, inspirational, and most importantly, useful. Join us as we partner with great global companies and outstanding investors from around the world like yourself who aspire to fight cancer, while simultaneously seeking to reap the personal and financial rewards for doing so. If you have any questions, please click on the CONTACT link found at the top or bottom of any page.

Thank you for the opportunity to share our vision, and once again welcome to Can Serve Free LLC - your investment advisory firm. 

Invest wisely in companies that fight cancer!

Eric Shea Broadus, Founder and CEO

Bio:

Eric’s previous professional experiences include various roles in international finance, foreign currency risk management, and healthcare/biotech finance, most notably working at the global medical devices company Stryker Corporation, at The Johns Hopkins University School of Medicine Department of Pediatric Oncology, at Catholic Health Initiatives (CHI) focusing on system-wide hospital operational performance analytics and mergers and acquisitions (M&A) reporting, and at Morgan Stanley (investment advisor trainee program).

Eric holds an investment advisor license, the Certified Treasury Professional (CTP) certification, a bachelor's degree in economics from Indiana University-Purdue University Indianapolis (IUPUI) and a master's degree in international relations from The Johns Hopkins University (School of Advanced International Studies).

He is the survivor of acute myeloid leukemia (AML) and the author of the book, "Invest in Cancer Stocks: Make Money and Make a Difference."  

Eric resides with his family in the Atlanta, Georgia area.